Gene: C11orf54
Official Full Name: chromosome 11 open reading frame 54provided by HGNC
Gene Summary: Enables hydrolase activity, acting on ester bonds and zinc ion binding activity. Located in nuclear body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27279 | C11orf54 Knockout cell line (HeLa) | Human | C11orf54 | 1:3~1:6 | Negative | Online Inquiry |
KO27280 | C11orf54 Knockout cell line (HCT 116) | Human | C11orf54 | 1:2~1:4 | Negative | Online Inquiry |
KO27281 | C11orf54 Knockout cell line (HEK293) | Human | C11orf54 | 1:3~1:6 | Negative | Online Inquiry |
KO27282 | C11orf54 Knockout cell line (A549) | Human | C11orf54 | 1:3~1:4 | Negative | Online Inquiry |
C11orf54 Gene Knockout Cell Lines represent an advanced genetic tool designed to facilitate the study of the C11orf54 gene's functions and its implications in various biological processes. These cell lines have been meticulously engineered to precisely remove the C11orf54 gene, allowing researchers to investigate the resultant phenotypic and functional changes in cellular behavior. The knockout mechanism is achieved through techniques such as CRISPR-Cas9 or homologous recombination, enabling the selective disruption of the gene without affecting adjacent genomic regions, thus ensuring experimental fidelity.
The primary role of C11orf54 Gene Knockout Cell Lines lies in their ability to elucidate the gene’s involvement in critical pathways, such as cellular proliferation, differentiation, and response to stimuli. By studying these knockout models, researchers can gain insights into the gene's relevance in various pathological conditions, including cancers and metabolic disorders. This specificity allows for targeted experimentation, enabling a deeper understanding of the gene's role in human health and disease.
From a scientific perspective, these knockout cell lines are invaluable for drug discovery, genetic research, and the development of therapeutic strategies. By defining the functional roles of the C11orf54 gene, they pave the way for novel interventions and biomarkers, significantly contributing to clinical applications and potentially improving patient outcomes.
One of the standout features of our C11orf54 Gene Knockout Cell Lines is their reliability and reproducibility, crucial for any rigorous scientific inquiry. Unlike other methods that might introduce off-target effects or yield inconsistent results, our knockout lines have been validated through comprehensive genomic and phenotypic analyses, ensuring robust data generation.
For researchers and clinicians aiming to bridge the gap between basic research and clinical applications, the C11orf54 Gene Knockout Cell Lines deliver exceptional value. They facilitate the exploration of gene functions and their implications in diseases, empowering the scientific community to develop targeted therapeutic approaches.
Our company is dedicated to providing cutting-edge biological products supported by extensive research and development expertise, ensuring that our clients have access to the latest tools necessary for driving innovative discoveries in the realm of genetic research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.